Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2004
02/19/2004CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation
02/19/2004CA2492019A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors
02/18/2004EP1389616A1 Novel benzylpiperidine compound
02/18/2004EP1389611A1 20-hydroxyeicosatetraenoic acid production inhibitors
02/18/2004EP1389460A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound
02/18/2004EP1389205A1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
02/18/2004EP1389204A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
02/18/2004EP1389203A2 Analogs of thalidomide as potential angiogenesis inhibitors
02/18/2004EP1389201A1 N-oxide anthranylamide derivatives and their use as medicaments
02/18/2004EP1389200A1 Substituted n-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors
02/18/2004EP1389194A2 Inhibitors of bace
02/18/2004EP1389190A1 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring
02/18/2004EP1389189A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
02/18/2004EP1389184A2 Methods of preparing sulfinamide and sulfoxides
02/18/2004EP1389110A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
02/18/2004EP1389107A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
02/18/2004EP1389104A2 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
02/18/2004EP1389103A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
02/18/2004EP1389100A2 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
02/18/2004EP1213281B1 Novel amide derivatives
02/18/2004EP1196410B1 Respiratory syncytial virus replication inhibitors
02/18/2004EP1183252B1 pharmaceutically active compounds
02/18/2004EP1178958B1 N-cyanomethyl amides as protease inhibitors
02/18/2004EP1133477B1 Substituted benzimidazoles and their use as parp inhibitors
02/18/2004CN1476448A Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
02/18/2004CN1476446A Benzodiazepine derivative
02/18/2004CN1476445A 4-(bipheny/carbony/amino) piperidine derivatives as MTP inhibitors
02/18/2004CN1476444A Farnesyl protein transferase inhibitors
02/18/2004CN1476443A New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
02/18/2004CN1476442A Pyridine derivatives with IKB-kinase (IKK-beta) INhibiting activity
02/18/2004CN1476436A Novel compounds for use as HIV protease inhibitors
02/18/2004CN1476434A Novel compounds
02/18/2004CN1476433A Substituted benzene derivatives or salts thereof
02/18/2004CN1476432A Indole and dihydroindole derivatives
02/18/2004CN1476430A Delta 1-pyrrolines used as pesticides
02/18/2004CN1138773C 4-alkenyl (and alkynyl) oxindoles as inhibitors of cell cycle protein dependent kinases, in particular CDK2
02/18/2004CN1138761C 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and use as dopamine autoreceptor (D2) agonists
02/18/2004CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
02/18/2004CN1138758C Tetrahydropyridines as pesticides
02/18/2004CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
02/17/2004US6693200 2-(substituted-phenyl)amino-imidazoline derivatives
02/17/2004US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter
02/17/2004US6693197 Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino- [2,3-f] quinoline
02/17/2004US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia
02/17/2004US6693121 As inhibitors of serine proteases of the coagulation cascade and compounds, used for anticoagulant therapy forprophylaxis of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases
02/17/2004US6693118 E.G., 1-(2-(6,7-METHYLENEDIOXYNAPHTH-2-YL)-ETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6-TETRAHYDROPYRIDINE AND 1-2-(4-CYCLOHEXENYLPHENYL)-ETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6 -TETRAHYDROPYRIDINE; apoptosis inhibition; treatment of graft rejection or of acute or chronic rheumatoid arthritis
02/17/2004US6693117 Compounds with analgesic effect
02/17/2004US6693113 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections
02/17/2004US6693112 Compounds for enhancing chemotherapy
02/17/2004US6693101 Alkanoic acid derivative; integrin receptor antagonist
02/17/2004US6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
02/17/2004US6693097 Antiinflammatory agents; antidiabetic agents; skin disorders; rheumatic diseases
02/17/2004US6692657 Alkenyl compound with 2,3-difluorophenyl group
02/17/2004CA2302965C Processes and intermediates for preparing anti-cancer compounds
02/17/2004CA2290918C Heteroaromatic bicyclic derivatives useful as anticancer agents
02/17/2004CA2280279C Indole, indazole and benzimidazole derivatives as antithrombotic agents
02/12/2004WO2004013633A2 Method for isolating atp binding proteins by means of immobolized protein inhibitors
02/12/2004WO2004013135A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
02/12/2004WO2004013131A2 Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl
02/12/2004WO2004013129A1 4-trifluoromethylpyrazolyl substituted pyridines and pyrimidines
02/12/2004WO2004013128A1 Novel substituted benzamides production and use thereof as medicaments
02/12/2004WO2004013127A1 Method for producing highly pure hydroxy indolyl glyoxylic acid amides
02/12/2004WO2004013126A1 Salt of (s)-pantoprazole and its hydrates
02/12/2004WO2004013125A1 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway
02/12/2004WO2004013124A1 Pyridyl-triazine derivatives as microbicidal active substances
02/12/2004WO2004013104A1 Novel tetrahydroquinoline derivatives
02/12/2004WO2004013102A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
02/12/2004WO2004013091A2 4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases
02/12/2004WO2004012739A1 Novel crystalline forms of gatifloxacin
02/12/2004WO2004012738A1 Novel salt and polymorphs of desloratadine hemifumarate
02/12/2004WO2004012736A1 Biaryl compounds having anti-infective activity
02/12/2004WO2004012733A2 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
02/12/2004WO2004012731A1 Pyrrolidine derivatives as tryptase inhibitors
02/12/2004WO2004012663A2 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
02/12/2004WO2004012659A2 Nitrosated proton pump inhibitors, compositions and methods of use
02/12/2004WO2004012648A2 Substituted diaryl heterocycles, method for the production and use thereof as medicaments
02/12/2004WO2003086275A3 Preperation of desloratatine
02/12/2004WO2003079787A9 Synergistic fungicide compositions containing at least one n-`(2-pyridinyl)methyl!-3-pyridinecarboxamide derivative and one or more further fungicides useful for controlling fungal plant diseases
02/12/2004WO2003049702A3 Vanilloid receptor ligands and their use in treatments
02/12/2004WO2003020700A3 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF
02/12/2004WO2003010159A8 Piperidine derivatives as nmda receptor antagonists
02/12/2004WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
02/12/2004US20040030138 Process for 8-carboxamido-2,6-methano-3-benzazocines
02/12/2004US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects
02/12/2004US20040029935 Heterocyclic aromatic compounds useful as growth hormone secretagogues
02/12/2004US20040029925 Central nervous system disorders; psychological disorders; gastrointestinal disorders
02/12/2004US20040029920 2-(biarylalkyl)amino-3-(heterocyclylcarbonylamino)-pyridine derivatives
02/12/2004US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence
02/12/2004US20040029916 Antiarthritic agents; skin disorders; Crohn's disease
02/12/2004US20040029915 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof
02/12/2004US20040029902 2,4-Pyrimidinediamine compounds and their uses
02/12/2004US20040029901 Obesity therapy; administering orlistat
02/12/2004US20040029898 Anticancer agents
02/12/2004US20040029888 Central nervous system disorders; psychological disorders
02/12/2004US20040029887 Cardiovascular disorders; antiinflammatory agents; central nervous system diosrders; psychological disorders
02/12/2004US20040029886 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides
02/12/2004US20040029883 Beta-amino acid compounds as integrin antagonists
02/12/2004US20040029882 Antimicrobial quinolones, their compositions and uses
02/12/2004US20040029881 Herbicides, and chemical intermediates thereof
02/12/2004US20040029880 Anthranyl amides and their use as medicaments